financetom
Business
financetom
/
Business
/
Relief for Alembic Pharma, United Phosphorous: SC sets aside NGT Order, rules against closure of Gujarat facilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Relief for Alembic Pharma, United Phosphorous: SC sets aside NGT Order, rules against closure of Gujarat facilities
Apr 3, 2020 1:22 AM

In a big relief for BSE listed Alembic Pharma and United Phosphorous, the Supreme Court of India (SC) has set aside a 2016 National Green Tribunal (NGT) order that had directed the closure of their facilities in Gujarat.

In January of 2016, the NGT had passed an order directing for revocation of the Environment Clearance and closure of the industrial units of Alembic Pharma and United Phosphorous. The NGT had passed orders for closure, after it had held that grant of ex-post-facto Environmental Clearance under the Ministry of Environment and Forests Circular of May 2002, was not sound in law.

A bench of SC headed by Justice DY Chandrachud, in its judgment noted, "Alembic Pharma, United Phosphorous operated for many years in Ankleshwar-Guj without the Environment Clearance." The Court also observed in the judgment, "Court cannot be oblivious to the environmental degradation caused by all three industries units that operated without valid ECs." The judgment also held that this was a clear case of companies having evaded the legally binding regime of obtaining ECs, cannot escape the liability.

However, interestingly, Justice DY Chandchud headed bench also reasoned, "Industrial units have made infrastructural investments and employed significant numbers of workers in their facilities." SC judgment held, "Court needs to take a balanced approach in light of economic interests, NGT directions for closure are not in keeping with principles of proportionality."

Stressing on the need for balance and proportionality, the SC held that NGT directing closure of industrial units was not warranted and consequently, set aside the NGT directions for bringing down the shutters.

However, as a rap on the knuckles, SC noted that penalties must be imposed for disobedience with a binding legal regime. SC has, therefore, directed for a levy of penalty of 10 cr on each of the errant companies. SC has directed the penalty amount to be used for the purpose of restitution and restoration of the environment. SC has also specified that the penalty amount to be deposited within 4 months of the judgment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Mastec Insider Sold Shares Worth $1,806,950, According to a Recent SEC Filing
Mastec Insider Sold Shares Worth $1,806,950, According to a Recent SEC Filing
Aug 7, 2025
05:12 PM EDT, 08/07/2025 (MT Newswires) -- Alberto de Cardenas, Executive Vice President, General Counsel, on August 05, 2025, sold 10,000 shares in Mastec ( MTZ ) for $1,806,950. Following the Form 4 filing with the SEC, de Cardenas has control over a total of 109,433 common shares of the company, with 101,349 shares held directly and 8,084 controlled indirectly....
Inuvo reports smaller-than-expected net loss in Q2
Inuvo reports smaller-than-expected net loss in Q2
Aug 7, 2025
Overview * Inuvo Q2 2025 revenue rises 25% yr/yr but missed analyst expectations * Adjusted loss per share for Q2 meets analyst expectations, net loss beats estimates * Company reports lower gross margin due to change in product mix Result Drivers * PLATFORM CLIENTS - Revenue growth attributed to increased sales from largest platform clients * PRODUCT MIX - Lower...
Doximity Fiscal Q1 Non-GAAP EPS, Revenue Rise; Acquires Pathway Medical
Doximity Fiscal Q1 Non-GAAP EPS, Revenue Rise; Acquires Pathway Medical
Aug 7, 2025
05:12 PM EDT, 08/07/2025 (MT Newswires) -- Doximity ( DOCS ) reported fiscal Q1 non-GAAP earnings Thursday of $0.36 per diluted share, up from $0.28 a year earlier. Analysts polled by FactSet expected $0.30. Revenue for the quarter ended June 30 was $145.9 million, up from $126.7 million a year earlier. Analysts surveyed by FactSet expected $139.5 million. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved